## AJG: Arthur J. Gallagher & Co. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 0.9% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($250.53)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Arthur J. Gallagher (NYSE:AJG) Reports Sales Below Analyst Estimates In Q3 CY2025 Earnings**
- Source: Finviz | 20251223T150735 | Neutral | Relevance: 100%
- Arthur J. Gallagher (NYSE:AJG) reported Q3 CY2025 earnings with revenue of $3.37 billion, missing analyst estimates but showing 21.2% year-on-year growth. Adjusted EPS of $2.32 also fell short of expectations. Despite solid long-term revenue and EPS growth, the company's Q3 performance was below projections, leading to the stock remaining flat post-results.

**2. Arthur J. Gallagher (NYSE:AJG) Reports Sales Below Analyst Estimates In Q3 CY2025 Earnings**
- Source: TradingView â€” Track All Markets | 20251223T150717 | Somewhat-Bearish | Relevance: 100%
- Arthur J. Gallagher (NYSE:AJG) reported Q3 CY2025 earnings with revenue of $3.37 billion, missing analyst estimates of $3.46 billion, although sales increased 21.2% year-on-year. The company's non-GAAP profit of $2.32 per share also fell short of analysts' consensus estimates by 8.5%. Despite these shortfalls, the company demonstrated strong long-term revenue and EPS growth, with analysts projecting significant revenue and EPS growth for the next 12 months.

**3. Walter Bay At Arthur J. Gallagher Decides to Exercises Options Worth $2.85M**
- Source: Benzinga | 20251224T150741 | Bullish | Relevance: 100%
- Walter Bay, General Counsel at Arthur J. Gallagher (NYSE: AJG), recently exercised stock options for 15,850 shares, valued at $2,849,354. This transaction, detailed in a Form 4 filing, involved shares priced at $259.36. The company, an insurance brokerage firm, exhibits strong revenue growth but faces challenges with gross margins, while its EPS is higher than the industry average.

**4. Yousif Capital Management LLC Has $9.15 Million Stock Position in Arthur J. Gallagher & Co. $AJG**
- Source: MarketBeat | 20251224T144204 | Neutral | Relevance: 100%
- Yousif Capital Management LLC reduced its stake in Arthur J. Gallagher & Co. (NYSE:AJG) by 11.9% in Q3, ending the quarter with a $9.15 million position. Insider selling has also occurred, with General Counsel Walter D. Bay selling 15,850 shares for $4.04 million. Wall Street analysts currently rate AJG as a "Moderate Buy" with a consensus price target of $302.22, despite the company missing recent quarterly EPS estimates.

**5. Walter Bay Sells 15,850 Shares of Arthur J. Gallagher & Co. (NYSE:AJG) Stock**
- Source: MarketBeat | 20251224T022125 | Somewhat-Bearish | Relevance: 100%
- Walter Bay, General Counsel of Arthur J. Gallagher & Co. (NYSE:AJG), sold 15,850 shares of the company's stock on December 19th for a total value of $4.04 million, reducing his stake by 16.61%. The company's stock traded up on Tuesday, with a market capitalization of $66.44 billion, and recently announced a quarterly dividend of $0.65 per share. Analysts have a "Moderate Buy" rating on the stock with an average target price of $302.22, while institutional investors hold approximately 85.53% of the shares.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 7)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Wells Fargo | $344 | $328 | +5% |
| 2025-12-22 | Wells Fargo | $328 | $344 | -5% |
| 2025-12-19 | Morgan Stanley | $300 | $0 | 0% |
| 2025-12-18 | Keefe, Bruyette | $272 | $275 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Wells Fargo | main | Overweight |
| 2025-12-22 | Wells Fargo | main | Overweight |
| 2025-12-19 | Morgan Stanley | init | Overweight |
| 2025-12-18 | Keefe, Bruyette | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.55M) |
| Sells | 2 ($1.88M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 15.8% (+139.2%)
- Vanguard Group Inc: 12.1% (+0.2%)
- Blackrock Inc.: 7.2% (-2.2%)
- FMR, LLC: 4.9% (-4.1%)
- Capital World Invest: 4.6% (+0.9%)

### Key Risks

1. Long-term trend broken: trading 13.5% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.83 indicates undervaluation relative to growth. Forward P/E 19.5x attractive for 25% earnings growth. Revenue growth strong at 22% YoY. Analyst sentiment negative (7 target cuts vs 1 raises). Insider selling cluster ($1.9M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $67.0B |
| Beta | 0.69 |
| 52W Range | $236.34 - $351.23 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.83 |
| Forward P/E | 19.5 |
| Current P/E | 24.3 |
| YoY Growth | 24.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.4% to 0.9% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.1pp (needs >3.0% for momentum thesis). MRS_5 at 0.6% confirms short-term momentum alignment. Below SMA200 (0.86x), long-term trend not supportive. MACD histogram positive (2.44), confirming momentum. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.90% (CS: 86) | Neutral |
| RSI_14 | 60.6 | Neutral |
| MACD Histogram | 2.44 | Bullish |
| vs SMA20 | 1.047x | Above |
| vs SMA50 | 1.016x | Above |
| vs SMA200 | 0.865x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $260.83
- **Stop Loss:** $250.53 (3.9% risk)
- **Target:** $271.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 139
- **Position Value:** $36,255.37
- **Portfolio %:** 36.26%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-01-29 (Est: $2.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.54 | $2.32 | -8.5% |
| 2025Q2 | $2.34 | $2.33 | -0.6% |
| 2025Q1 | $3.58 | $3.67 | +2.5% |
| 2024Q4 | $2.03 | $2.13 | +5.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*